Xenetic Biosciences Insider Trades

XBIO

Track insider trading activity from Xenetic Biosciences executives and directors. See which insiders are buying and selling XBIO stock.

Trades Last 12 Months

XBIO Price

All Insider Trades for Xenetic Biosciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Parslow James F Interim CEO And CFO
Holding Value $342k 100,000 shares
Last Trade
Apr 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$313k 100,000 shares
$3.13
$3.42
Holding Value $8.55k 2,500 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.43k 2,500 shares
$2.17
$3.42
Holding Value $8.55k 2,500 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.43k 2,500 shares
$2.17
$3.42
Holding Value $8.55k 2,500 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.43k 2,500 shares
$2.17
$3.42
Holding Value $8.55k 2,500 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.43k 2,500 shares
$2.17
$3.42
Lockshin Curtis Chief Sciencific Officer
Holding Value $34.2k 10,000 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.8k 10,000 shares
$3.88
$3.42
Eisenberg Jeffrey F Chief Executive Officer
Holding Value $68.4k 20,000 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$77.6k 20,000 shares
$3.88
$3.42
Holding Value $8.55k 2,500 shares
Last Trade
Dec 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.7k 2,500 shares
$4.29
$3.42
Logal Adam Director
Holding Value $8.55k 2,500 shares
Last Trade
Dec 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.7k 2,500 shares
$4.29
$3.42
Mizrahy Moshe Director
Holding Value $8.55k 2,500 shares
Last Trade
Dec 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.7k 2,500 shares
$4.29
$3.42
Genkin Dmitry Director
Holding Value $320k 93,603 shares
Last Trade
Jul 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.3M 93,390 shares
$485.00
$3.42
Holding Value $1.52M 443,786 shares
Last Trade
Dec 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.8B 250,000 shares
$51,350.40
$3.42
Pjsc Pharmsynthez 10% owner
Holding Value $0 0 shares
Last Trade
Nov 07, 2016 Sale
$86.9B 1,454,545 shares
$59,760.00
$3.42
Knyazev Roman Director
Holding Value $0 0 shares
Last Trade
Nov 01, 2016 Sale
$540M 37,879 shares
$14,256.00
$3.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up